Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Transasia Bio-Medicals Signs An Agreement With Grifols

Transasia Bio-Medical Ltd. has signed an agreement with Grifols, Spain to exclusively distribute its range of instruments and reagents in the field of transfusion medicine in the Indian market. Through this partnership with Grifols, Spain, Transasia Bio-Medical will now offer a complete portfolio of products in the transfusion  medicine space in the Indian market.

The new line of products that Transasia would distribute would be WaDiana Compact®, DG Spin™, DG Therm™ in the instruments section, DG Gel® cards and Grifols Red Blood Cells in the reagents section. DG Gel® cards and Grifols Red Blood Cells, which are based on Gel Test™ technology, is tomation meets the need for ABO and Rh typing, antibody screening and identification, compatibility testing, reverse serum grouping, and antigen typing.

(Ref: The Medical Buyer dated November 2007)

GE Healthcare's Dexa Scan To Speed Up Bone Mineral Density Testing In Rural Areas

GE Healthcare's advanced bone mineral density scan system, Dexa Scan, is expected to provide easy and simple diagnosis to the patients in the far flung regions of the country. Dexa scan is based on "fan-beam" X-ray bone densitometer technology fitted in a mobile van. It operates on Dual-Energy X-ray Absorbtiometry and is used to measure and calculate bone, fat and muscle mass.

Dexa scans is considered to be the 'gold standard' for physicians to detect and diagnose skeletal diseases, including osteoporosis. It can also perform vertebral imaging.

GE's novel mobile prodigy and other lunar technologies help to detect low bone mass and increased risk of facture, with direct digital technology, precision and accuracy.

"Rather than the patient driving farther for BMD and body composition testing, we can bring these advanced healthcare technologies closer to the patient's home," said Laura Stoltenberg, general manager, GE Healthcare's Lunar business.

GE Lunar also will demonstrate unique technology to help physicians measure BMD in children, as well as systems to enable licensed medical practitioners to simultaneously assess body composition and ascertain fat distribution in adults.

GE Lunar feature enhanced enCORE software which will allow physicians to measure a child's bone density, fat and lean tissue mass composition, by factoring in and trending the child's age, height and other variables. It will enable the physician to separate out the child's growth from other changes to the size and density of the skeleton.

In addition to the BMD assessment, a new body composition software systems can help people and their physicians establish goals for weight loss, exercise and diet regimes.

Lunar systems work by measuring the regional and whole body BMD, plus lean and fat tissue mass. It calculates the derivative values that can be displayed in user-defined statistical formats.

The body composition values are useful to licensed medical practitioners in their management of diseases and conditions. However the option does not diagnose a disease, or recommend treatment regiments, or quantify treatment effectiveness. Only the licensed medical practitioner can make these judgments. Some of the diseases or conditions for which body or conditions for which body composition values are useful include chronic renal failure, anorexia nervosa, obesity, AIDS/HIV and cystic fibrosis.

Lunar iDXA software also gives physicians dedicated reporting for body composition measurements and high percentage color fat mapping. Patients can easily follow the report divided into three compartments: lean mass, total body tissue percent fat, and bone density.

(Ref: The Chronicle Pharmabiz dated November 29, 2007)


Other News

World's 1st 3D ICU Ventilator Launched
Mobile To Revolutionize Healthcare In Korea
Jubilant Organosys Bags Golden Peacock Global Award 2007
'Destiny'- a New Digital Aid For Indian Market By Starkey
Bayer's New Contour TS Blood Glucose Monitor Launched
Roche Launches Insulin Pump
HSBC PE (Asia) Fund, ePlanet To Invest US$ 11 Mn In Trivitron
Fresenius Group Net Profit Up By 28%
GE, Eli Lilly To Collaborate In Vitro Diagnostics For Cancer Treatment
Metropolis To Start Operations In US, Thailand With Investment In JV, Acquisition
Alcon India Launches AcrySof® Restor® Lens
GE Healthcare To Augment Engg. Head Count By 10%
Indian Pharma Machinery Makers Go For Overseas Tie-Ups For Growth





Back | Back To Top | Previous | Next